Abstract 437: Computational discovery and preclinical validation of therapeutic leads with novel MOAs for Glioblastoma
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-437
Abstract: Glioblastoma (GBM) is an aggressive, highly invasive tumor that has a 5-year survival rate of less than 5%, with median survival of approximately 15 months. Treatment options for patients with GBM are relatively unchanged over… read more here.
Keywords: kinase; inhibitor; inhibitor positive; novel moas ... See more keywords